Here are six gastroenterologists who recently made headlines.
GI & Endoscopy
Michael Phalen, acting executive vice president and president-MedSurg of Boston Scientific, recently sold 35,000 shares of the firm, according to a Franklin Independent report.
CMS' recently released proposed rule implements certain provisions of the Medicare Access and CHIP Reauthorization Act, according to an AGA report.
Early initiation of diuretic therapy in patients with new onset cirrhotic ascites lowers 90-day mortality rate, according to a study in the American Journal of Gastroenterology.
In a study published in Clinical Gastroenterology and Hepatology, researchers did not observe increased prevalence of microscopic colitis among irritable bowel syndrome patients versus other patients with diarrhea undergoing colonoscopy.
Manu R. Sood, MD, is a pediatric gastroenterologist and medical director of gastroenterology at Children's Hospital of Wisconsin in Milwaukee.
New York State Assemblyman David I. Weprin, joined Citizens for Safe Endoscopy and the Esophageal Cancer Awareness Association, to announce that the Upper Endoscopy Reform Act has been introduced in the assembly.
The presence of certain bacteria in the mouth may indicate increased risk for pancreatic cancer, according to a study conducted at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center, both in New York City.
DeltaStyle Magazine honored Brian T. Levatino, MD, as a 2016 Health Care Hero, according to The News Star.
A study published in the journal Genome Medicine shows the bacteria in people's gut may predict their risk of life-threatening blood infections following high-dose chemotherapy, as reported by Infection Control Today.
